Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Xtant Medical Holdings (XTNT) Shares Outstanding (Weighted Average) (2016 - 2025)

Historic Shares Outstanding (Weighted Average) for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $139.7 million.

  • Xtant Medical Holdings' Shares Outstanding (Weighted Average) rose 341.43% to $139.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $139.7 million, marking a year-over-year increase of 341.43%. This contributed to the annual value of $133.7 million for FY2024, which is 1223.52% up from last year.
  • Xtant Medical Holdings' Shares Outstanding (Weighted Average) amounted to $139.7 million in Q3 2025, which was up 341.43% from $139.3 million recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Shares Outstanding (Weighted Average) ranged from a high of $139.7 million in Q3 2025 and a low of $81.2 million during Q1 2021
  • For the 5-year period, Xtant Medical Holdings' Shares Outstanding (Weighted Average) averaged around $111.3 million, with its median value being $108.9 million (2023).
  • In the last 5 years, Xtant Medical Holdings' Shares Outstanding (Weighted Average) soared by 55571.62% in 2021 and then surged by 69.94% in 2022.
  • Over the past 5 years, Xtant Medical Holdings' Shares Outstanding (Weighted Average) (Quarter) stood at $85.5 million in 2021, then grew by 10.1% to $94.1 million in 2022, then rose by 26.58% to $119.1 million in 2023, then rose by 12.24% to $133.7 million in 2024, then grew by 4.52% to $139.7 million in 2025.
  • Its last three reported values are $139.7 million in Q3 2025, $139.3 million for Q2 2025, and $139.1 million during Q1 2025.